Success Through Centralization? The Path to Realizing Digital Pathology’s True Value

The Pathologist, September, 2021: Success Through Centralization? The Path to Realizing Digital Pathology’s True Value
By Flagship Biosciences Team Members: Geoffrey Metcalf, Meredith James, and Roberto Gianani

The PathologistDigital pathology’s benefits have been widely discussed – from alleviating staffing shortages to accelerating turnaround times; from increased consistency and accuracy to innovative teaching tools. But, in practice, those benefits have proven elusive. Why?

At its most intensive implementation, digital pathology has the potential to support primary clinical diagnosis. At a less intensive level, it can be used in targeted precision medicine applications, particularly in the area of immunohistochemistry tissue diagnostics. In all cases, though, the burdens of digitizing often outweigh the benefits – mainly because responsibility for the system’s performance rests with the local laboratory. Though many companies have created effective tools for managing slide images and streamlining workflow, they have done little to relieve the most time-intensive burden: the creation, validation, and maintenance of image analysis tools and diagnostic algorithms…

Geoffrey Metcalf – VP Clinical Diagnostics at Flagship Biosciences
Meredith James – Chief Commercial Officer at Flagship Biosciences
Roberto Gianani – Medical Director and Chief Medical Officer at Flagship Biosciences

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Recent Posts

Flagship Biosciences Is Honored with a Best Practices Award

We are honored to announce that Flagship Biosciences has earned a Frost & Sullivan 2023 North American Customer Value Leadership Award in the AI-enabled digital pathology solutions market. Following from detailed evaluation of best practices criteria, the award...

Flagship Biosciences hires Tom Turi, Ph.D. as CSO

Accomplished industry executive strengthens company’s position as a leader in spatial biology and biomarker analytics.BROOMFIELD, CO - September 27, 2022 — Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the hiring...